124 related articles for article (PubMed ID: 15541811)
21. Loss of heterozygosity of chromosome 3p21 is associated with mutant TP53 and better patient survival in non-small-cell lung cancer.
Marsit CJ; Hasegawa M; Hirao T; Kim DH; Aldape K; Hinds PW; Wiencke JK; Nelson HH; Kelsey KT
Cancer Res; 2004 Dec; 64(23):8702-7. PubMed ID: 15574780
[TBL] [Abstract][Full Text] [Related]
22. Focal cortical dysplasia of Taylor's balloon cell type: mutational analysis of the TSC1 gene indicates a pathogenic relationship to tuberous sclerosis.
Becker AJ; Urbach H; Scheffler B; Baden T; Normann S; Lahl R; Pannek HW; Tuxhorn I; Elger CE; Schramm J; Wiestler OD; Blümcke I
Ann Neurol; 2002 Jul; 52(1):29-37. PubMed ID: 12112044
[TBL] [Abstract][Full Text] [Related]
23. Proliferative activity, p53 expression and loss of heterozygosity on 3p, 9p and 17p in atypical adenomatous hyperplasia of the lung.
Kitaguchi S; Takeshima Y; Nishisaka T; Inai K
Hiroshima J Med Sci; 1998 Mar; 47(1):17-25. PubMed ID: 9583279
[TBL] [Abstract][Full Text] [Related]
24. Identification of loci associated with putative recurrence genes in transitional cell carcinoma of the urinary bladder.
Edwards J; Duncan P; Going JJ; Watters AD; Grigor KM; Bartlett JM
J Pathol; 2002 Apr; 196(4):380-5. PubMed ID: 11920732
[TBL] [Abstract][Full Text] [Related]
25. Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at distal 17p13.3 in human lung cancer.
Konishi H; Sugiyama M; Mizuno K; Saito H; Yatabe Y; Takahashi T; Osada H; Takahashi T
Oncogene; 2003 Mar; 22(12):1892-905. PubMed ID: 12660825
[TBL] [Abstract][Full Text] [Related]
26. Loss of heterozygosity of the Mutated in Colorectal Cancer gene is not associated with promoter methylation in non-small cell lung cancer.
Poursoltan P; Currey N; Pangon L; van Kralingen C; Selinger CI; Mahar A; Cooper WA; Kennedy CW; McCaughan BC; Trent R; Kohonen-Corish MR
Lung Cancer; 2012 Aug; 77(2):272-6. PubMed ID: 22542170
[TBL] [Abstract][Full Text] [Related]
27. Decreased expression of the SIN3A gene, a candidate tumor suppressor located at the prevalent allelic loss region 15q23 in non-small cell lung cancer.
Suzuki H; Ouchida M; Yamamoto H; Yano M; Toyooka S; Aoe M; Shimizu N; Date H; Shimizu K
Lung Cancer; 2008 Jan; 59(1):24-31. PubMed ID: 17854949
[TBL] [Abstract][Full Text] [Related]
28. Multifocal micronodular pneumocyte hyperplasia and lymphangioleiomyomatosis in tuberous sclerosis with a TSC2 gene.
Maruyama H; Seyama K; Sobajima J; Kitamura K; Sobajima T; Fukuda T; Hamada K; Tsutsumi M; Hino O; Konishi Y
Mod Pathol; 2001 Jun; 14(6):609-14. PubMed ID: 11406664
[TBL] [Abstract][Full Text] [Related]
29. Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung.
Yoshida Y; Shibata T; Kokubu A; Tsuta K; Matsuno Y; Kanai Y; Asamura H; Tsuchiya R; Hirohashi S
Lung Cancer; 2005 Oct; 50(1):1-8. PubMed ID: 15950315
[TBL] [Abstract][Full Text] [Related]
30. The 3p21 candidate tumor suppressor gene BAF180 is normally expressed in human lung cancer.
Sekine I; Sato M; Sunaga N; Toyooka S; Peyton M; Parsons R; Wang W; Gazdar AF; Minna JD
Oncogene; 2005 Apr; 24(16):2735-8. PubMed ID: 15735765
[TBL] [Abstract][Full Text] [Related]
31. Frequent genetic and epigenetic abnormalities contribute to the deregulation of cytoglobin in non-small cell lung cancer.
Xinarianos G; McRonald FE; Risk JM; Bowers NL; Nikolaidis G; Field JK; Liloglou T
Hum Mol Genet; 2006 Jul; 15(13):2038-44. PubMed ID: 16698880
[TBL] [Abstract][Full Text] [Related]
32. Molecular changes in second primary lung and breast cancers after therapy for Hodgkin's disease.
Behrens C; Travis LB; Wistuba II; Davis S; Maitra A; Clarke EA; Lynch CF; Glimelius B; Wiklund T; Tarone R; Gazdar AF
Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1027-35. PubMed ID: 11045784
[TBL] [Abstract][Full Text] [Related]
33. Mutation detection in tumor suppressor genes using archival tissue specimens.
Astrinidis A; Henske EP
Methods Mol Med; 2006; 126():185-96. PubMed ID: 16930013
[TBL] [Abstract][Full Text] [Related]
34. Methylation of RAS association domain family protein 1A as a biomarker of lung cancer.
Grote HJ; Schmiemann V; Geddert H; Bocking A; Kappes R; Gabbert HE; Sarbia M
Cancer; 2006 Apr; 108(2):129-34. PubMed ID: 16444703
[TBL] [Abstract][Full Text] [Related]
35. Hypermethylation of the GATA genes in lung cancer.
Guo M; Akiyama Y; House MG; Hooker CM; Heath E; Gabrielson E; Yang SC; Han Y; Baylin SB; Herman JG; Brock MV
Clin Cancer Res; 2004 Dec; 10(23):7917-24. PubMed ID: 15585625
[TBL] [Abstract][Full Text] [Related]
36. Analysis of p53 mutations in histologically normal lung tissues and lung tumors from non-small cell lung cancer patients.
Gao W; Mady HH; Melhem MF; Keohavong P
Mol Carcinog; 2009 Jul; 48(7):633-41. PubMed ID: 19072763
[TBL] [Abstract][Full Text] [Related]
37. [Minimal commonly deleted regions on chromosome 7q31 in primary gastric carcinoma and its clinical significance].
Li JT; Fu L; Xia JC; Feng BJ; Mai SJ; Yu XJ; Huang LX; Feng QS; Pan ZZ; Zhan YQ
Ai Zheng; 2005 Nov; 24(11):1306-11. PubMed ID: 16552953
[TBL] [Abstract][Full Text] [Related]
38. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
[TBL] [Abstract][Full Text] [Related]
39. Promoter methylation of DAL-1/4.1B predicts poor prognosis in non-small cell lung cancer.
Kikuchi S; Yamada D; Fukami T; Masuda M; Sakurai-Yageta M; Williams YN; Maruyama T; Asamura H; Matsuno Y; Onizuka M; Murakami Y
Clin Cancer Res; 2005 Apr; 11(8):2954-61. PubMed ID: 15837747
[TBL] [Abstract][Full Text] [Related]
40. Functional cloning of a tumor suppressor gene, TSLC1, in human non-small cell lung cancer.
Murakami Y
Oncogene; 2002 Oct; 21(45):6936-48. PubMed ID: 12362275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
